BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 10037277)

  • 1. Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis.
    Koyama S; Maruyama T; Adachi S
    J Cancer Res Clin Oncol; 1999; 125(1):47-54. PubMed ID: 10037277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD44 containing variant exon 9 (CD44v9) in gastric adenomas and adenocarcinomas: relation to the proliferation and progression.
    Yasui W; Kudo Y; Naka K; Fujimoto J; Ue T; Yokozaki H; Tahara E
    Int J Oncol; 1998 Jun; 12(6):1253-8. PubMed ID: 9592182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects.
    Harn HJ; Ho LI; Chang JY; Wu CW; Jiang SY; Lee HS; Lee WH
    Cancer; 1995 Mar; 75(5):1065-71. PubMed ID: 7531611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo expression of CD44 variants in sporadic and hereditary gastric cancer.
    da Cunha CB; Oliveira C; Wen X; Gomes B; Sousa S; Suriano G; Grellier M; Huntsman DG; Carneiro F; Granja PL; Seruca R
    Lab Invest; 2010 Nov; 90(11):1604-14. PubMed ID: 20856229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa.
    Heider KH; Dämmrich J; Skroch-Angel P; Müller-Hermelink HK; Vollmers HP; Herrlich P; Ponta H
    Cancer Res; 1993 Sep; 53(18):4197-203. PubMed ID: 7689929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
    Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
    Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma.
    van Hal NL; van Dongen GA; Stigter-van Walsum M; Snow GB; Brakenhoff RH
    Int J Cancer; 1999 Sep; 82(6):837-45. PubMed ID: 10446451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expressions of CD44 variants in tumors affecting the central nervous system.
    Resnick DK; Resnick NM; Welch WC; Cooper DL
    Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD44 splice variants in human skin and epidermal tumours.
    Seiter S; Tilgen W; Herrmann K; Schadendorf D; Patzelt E; Möller P; Zöller M
    Virchows Arch; 1996 Jun; 428(3):141-9. PubMed ID: 8688968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44V6 in gastric carcinoma: a marker of tumor progression.
    Xin Y; Grace A; Gallagher MM; Curran BT; Leader MB; Kay EW
    Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):138-42. PubMed ID: 11396631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of CD44 transcription variants in human digestive tract carcinomas and normal tissues.
    Higashikawa K; Yokozaki H; Ue T; Taniyama K; Ishikawa T; Tarin D; Tahara E
    Int J Cancer; 1996 Mar; 66(1):11-7. PubMed ID: 8608952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential histiotypic expression of CD44-isoforms in human lung cancer.
    Wimmel A; Schilli M; Kaiser U; Havemann K; Ramaswamy A; Branscheid D; Kogan E; Schuermann M
    Lung Cancer; 1997 Mar; 16(2-3):151-72. PubMed ID: 9152947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancer.
    Shimabukuro K; Toyama-Sorimachi N; Ozaki Y; Goi T; Furukawa K; Miyasaka M; Aso T
    Gynecol Oncol; 1997 Jan; 64(1):26-34. PubMed ID: 8995543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas.
    Jackson DG; Schenker T; Waibel R; Bell JI; Stahel RA
    Int J Cancer Suppl; 1994; 8():110-5. PubMed ID: 7515025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
    Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M
    J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of standard and variant CD44 in human lung cancer].
    Zhao H; Fang J; Du G
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):541-3. PubMed ID: 11360506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of costimulatory molecules, B7-1 and B7-2 on human gastric carcinoma.
    Koyama S; Maruyama T; Adachi S; Nozue M
    J Cancer Res Clin Oncol; 1998; 124(7):383-8. PubMed ID: 9719501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis.
    Kunishi M; Kayada Y; Yoshiga K
    Int J Oral Maxillofac Surg; 1997 Aug; 26(4):280-3. PubMed ID: 9258720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD44H and CD44v3 in normal oesophagus, Barrett mucosa and oesophageal carcinoma.
    Castellà E; Ariza A; Fernández-Vasalo A; Roca X; Ojanguren I
    J Clin Pathol; 1996 Jun; 49(6):489-92. PubMed ID: 8763264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells.
    Bendall LJ; Bradstock KF; Gottlieb DJ
    Leukemia; 2000 Jul; 14(7):1239-46. PubMed ID: 10914548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.